Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12333)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 28, 2022 (publication date) through Mar 1, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Warner JB, Guenthner SC, Hardesty JE, McClain CJ, Warner DR, Kirpich IA. Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease. World J Gastroenterol 2022; 28(36): 5280-5299 [PMID: 36185629 DOI: 10.3748/wjg.v28.i36.5280] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Warner JB, Guenthner SC, Hardesty JE, McClain CJ, Warner DR, Kirpich IA. Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease. World J Gastroenterol 2022; 28(36): 5280-5299 [PMID: 36185629 DOI: 10.3748/wjg.v28.i36.5280] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v28/i36/5280.htm |
| Number | Citing Articles |
| 1 |
Tejinder Pal Singh, Saurabh Kadyan, Harisha Devi, Gwoncheol Park, Ravinder Nagpal. Gut microbiome as a therapeutic target for liver diseases. Life Sciences 2023; 322: 121685 doi: 10.1016/j.lfs.2023.121685
|
| 2 |
Naoto Fujiwara, Genki Kimura, Hayato Nakagawa. Emerging Roles of Spatial Transcriptomics in Liver Research. Seminars in Liver Disease 2024; 44(02): 115 doi: 10.1055/a-2299-7880
|
| 3 |
Gaurav Mittal, Prashanth A, Arkadeep Dhali, Roshan Prasad, Yogesh S, Khulud Mahmood Nurani, Mihnea-Alexandru Găman. Plant extracts with antioxidant and hepatoprotective benefits for liver health: A bibliometric analysis of drug delivery systems. World Journal of Gastroenterology 2025; 31(18): 105836 doi: 10.3748/wjg.v31.i18.105836
|
| 4 |
Dennis R. Warner, Jeffrey B. Warner, Josiah E. Hardesty, Yasmeen Abdelfadil, Chirag Soni, Philip Bauer, Claudio Maldonado, Craig J. McClain, Irina A. Kirpich. Hepatocyte-Specific Transcriptional Responses to Liver-Targeted Delivery of a Soluble Epoxide Hydrolase Inhibitor in a Mouse Model of Alcohol-Associated Liver Disease. Biology 2025; 14(9): 1267 doi: 10.3390/biology14091267
|
| 5 |
Xuehan Li, Haiyang Zhang, Xiangzhao Mao. Food-borne Delivery Systems of Functional Substances for Precision Nutrition. Advances in Food and Nutrition Research 2024; 112: 257 doi: 10.1016/bs.afnr.2024.06.010
|
| 6 |
Ziyi Zhang, Ruxin Chang, Qing Yue, Bin Liu, Zekun Li, Yu Yuan, Shuang Liang, Yuan Li. Food-borne Delivery Systems of Functional Substances for Precision Nutrition. Advances in Food and Nutrition Research 2024; 112: 51 doi: 10.1016/bs.afnr.2024.05.008
|
| 7 |
Tian Liu, Chun Li, Guofang Zhang, Libo Liu, Wenjing Li, Liying Wang, Peng Du. Mechanism of action of postbiotics intervention in alcoholic liver injury and future research directions. Food Nutrition 2026; : 100057 doi: 10.1016/j.fnutr.2026.100057
|
| 8 |
S. V. Tsaregorodtsev, I. V. Maev, A. V. Zaborovskiy, N. A. Pyataev, L. A. Tararina, A. G. Mulyar, M. Yu. Savelyev, A. V. Vychkin, N. V. Kheladze, I. M. Dadayeva. Nanosomal Forms of Hepatoprotectors in Acute Liver Injury: A Review. Pharmaceutical Chemistry Journal 2026; doi: 10.1007/s11094-026-03495-4
|
| 9 |
Jin Seok Hwang, Trang Huyen Lai, Deok Ryong Kim. Targeting Lipophagy in Liver Diseases: Impact on Oxidative Stress and Steatohepatitis. Antioxidants 2025; 14(8): 908 doi: 10.3390/antiox14080908
|
| 10 |
Janitha M. Unagolla, Riley Flanagan, Kalindu Perera, Youbin Kim, Curtis Soloff, Emily Kaye, Angela Slitt, Jyothi U. Menon. A novel Kupffer cell-targeting nanoparticle system to Mitigate alcohol-associated liver disease. Biomaterials 2026; 325: 123623 doi: 10.1016/j.biomaterials.2025.123623
|
| 11 |
Yedi Herdiana, Jutti Levita, Supat Jiranusornkul. Chitosan-Based Nanoparticles Targeted Delivery System: In Treatment Approach for Dyslipidemia. International Journal of Nanomedicine 2025; : 6611 doi: 10.2147/IJN.S517492
|
| 12 |
Thiago Oliveira, Gleisy Gonçalves. State-of-the-art Evaluation and Management of Hepatobiliary Diseases [Working Title]. 2026; doi: 10.5772/intechopen.1012571
|
| 13 |
Srikar Grandhi, Moawia Al-Tabakha, Prameela Rani Avula, Kuldeep Singh. Enhancement of Liver Targetability through Statistical Optimization and Surface Modification of Biodegradable Nanocapsules Loaded with Lamivudine. Advances in Pharmacological and Pharmaceutical Sciences 2023; 2023: 1 doi: 10.1155/2023/8902963
|
| 14 |
Zi Hong Mok. The effect of particle size on drug bioavailability in various parts of the body. Pharmaceutical Science Advances 2024; 2: 100031 doi: 10.1016/j.pscia.2023.100031
|
| 15 |
Nura Adam Mohamed, Farah Atifi, Zineb Ourradi, Sergio Crovella, Moutaz Derbala, Hadi M. Yassine, Ejaife O. Agbani, Yahye Merhi, Younes Zaid, Haissam Abou-Saleh. Nanoparticle approaches for hepatitis therapy and clinical translation. Discover Nano 2026; 21(1) doi: 10.1186/s11671-026-04450-8
|
| 16 |
Shaira Gail Santos, Khaja Shameem Mohammed Abdul, Nicole H Purcell. Protein phosphatases in metabolic dysfunction-associated steatotic liver disease: emerging mechanisms and therapeutic strategies. Current Opinion in Physiology 2025; 46: 100860 doi: 10.1016/j.cophys.2025.100860
|
| 17 |
Qian-Lan Wu, Jing Li, Tian-Le Mao, Xin Guo, Zhi-Jing Ni, Kiran Thakur, Yi-Long Ma, Zhao-Jun Wei. In vitro bioaccessibility and alcoholic injury-alleviation effect of Lycium barbarum leaf phenolics. Journal of Future Foods 2026; doi: 10.1016/j.jfutfo.2026.01.012
|
| 18 |
Janitha M. Unagolla, Subarna Das, Riley Flanagan, Marin Oehler, Jyothi U. Menon. Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives. International Journal of Pharmaceutics 2024; 660: 124381 doi: 10.1016/j.ijpharm.2024.124381
|
| 19 |
Ankit Jain, Ashwini Kumar Mishra, Pooja Hurkat, Satish Shilpi, Nishi Mody, Sanjay Kumar Jain. Navigating liver cancer: Precision targeting for enhanced treatment outcomes. Drug Delivery and Translational Research 2025; 15(6): 1935 doi: 10.1007/s13346-024-01780-x
|
| 20 |
Shivam Verma, Priyanka Maurya, Shailendra K. Saraf, Neelam Datt. Ameliorative effect of dextrose coated rebamipide liposomes for liver cirrhosis: in vitro and in vivo characterization. Future Journal of Pharmaceutical Sciences 2025; 11(1) doi: 10.1186/s43094-025-00826-2
|
| 21 |
Ming-Fo Hsu, Shinichiro Koike, Chang-Shan Chen, Sonia M. Najjar, Tzu-Ching Meng, Fawaz G. Haj. Pharmacological inhibition of the Src homology phosphatase 2 confers partial protection in a mouse model of alcohol-associated liver disease. Biomedicine & Pharmacotherapy 2024; 175: 116590 doi: 10.1016/j.biopha.2024.116590
|
| 22 |
Mona M. AbouSamra. Liposomal nano-carriers mediated targeting of liver disorders: mechanisms and applications. Journal of Liposome Research 2024; 34(4): 728 doi: 10.1080/08982104.2024.2377085
|
| 23 |
|
| 24 |
Vikas Gupta, Tejasav S. Sehrawat, Massimo Pinzani, Mario Strazzabosco. Portal Fibrosis and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease and Translational Opportunities. Gastroenterology 2025; 168(4): 675 doi: 10.1053/j.gastro.2024.07.044
|